Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6193959 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
High chemokine CCL2 expression is an independent predictor of recurrence in ccRCC patients. Evaluation of CCL2 could help guide postsurgical management for ccRCC patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yuanfeng M.D., Ph.D., Changwen M.D., Yuan M.D., Lin M.D., Tianming M.D., Cheng M.D., Ph.D., Le M.D., Ph.D., Jiejie Ph.D.,